Viewing StudyNCT00086632



Ignite Creation Date: 2024-05-05 @ 11:36 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00086632
Status: TERMINATED
Last Update Posted: 2007-12-18
First Post: 2004-07-07

Brief Title: Study of Ovarex Oregovomab MAb With Front-Line Chemotherapy for Ovarian Cancer Treatment
Sponsor: Unither Pharmaceuticals
Organization: Unither Pharmaceuticals

Conditions & Keywords Data

Conditions:
Name
Ovarian Cancer
Keywords:
Name View
front-line View
oregovomab View
ovarex View
ovarian cancer View
ovary View
ovarian carcinoma View